ICG-Guided vs. Traditional Lymphatic Drainage for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
Breast cancer is estimated to affect approximately 300,000 women in the US in 2023. Studies demonstrate that 1 in 5 will develop breast cancer related lymphedema secondary to the treatments that they receive. BCRL at this time has no cure, however early detection can prevent the progression to late stage BCRL. At this time a technique of arm massage, manual lymphatic drainage (MLD), is used for treatment. This study investigates a new method of MLD, which is guided by the individual patients' lymphatic anatomy through use of ICG-lymphography.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What makes ICG-guided manual lymphatic drainage unique compared to traditional methods for breast cancer treatment?
ICG-guided manual lymphatic drainage uses indocyanine green (ICG) to provide real-time fluorescent imaging, which helps in accurately mapping lymphatic pathways and potentially improving the effectiveness of lymphatic drainage compared to traditional methods that do not use this imaging technique.12345
What data supports the effectiveness of the treatment ICG-guided manual lymphatic drainage for breast cancer?
Research shows that manual lymphatic drainage (MLD) can improve the quality of life in patients with chronic venous disease and is used in breast cancer-related lymphedema. Indocyanine green (ICG) lymphography helps guide personalized MLD, which has been integrated into clinical practice to manage lymphedema effectively.16789
Who Is on the Research Team?
Lisa Spiguel, MD
Principal Investigator
University of Florida
Are You a Good Fit for This Trial?
This trial is for breast cancer patients undergoing axillary node dissection. It's designed to see if a new type of manual lymphatic drainage (MLD) guided by indocyanine-green (ICG) imaging can help prevent lymphedema, which is swelling due to fluid build-up after breast cancer treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive manual lymphatic drainage (MLD) guided by either ICG-lymphography or traditional methods
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ICG-guided manual lymphatic drainage
- Traditional manual lymphatic drainage
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor